INTERNATIONAL PATENT: ZETAGEN THERAPEUTICS, INC. FILES APPLICATION FOR "CONTROLLED RELEASE FORMULATION AND MINIMALLY INVASIVE METHOD OF ADMINISTRATION"

GENEVA, Feb. 18 -- ZETAGEN THERAPEUTICS, INC. (841 E. Fayette St., Ste. 100Syracuse, New York 13210) filed a patent application (PCT/US2024/041030) for "CONTROLLED RELEASE FORMULATION AND MINIMALLY INVASIVE METHOD OF ADMINISTRATION" on Aug 06, 2024. With publication no. WO/2025/034698, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MARGULIES, Bryan S. (c/o ZETAGEN THERAPEUTICS, INC.841 E. Fayette St., Ste. 100Syracuse, New York 13210)

Abstract: A controlled release formulation comprising an opioid growth factor recept...